Cargando…
Clinical Strategies for Enhancing the Efficacy of CAR T-Cell Therapy for Hematological Malignancies
SIMPLE SUMMARY: Cellular immunotherapy has achieved great progress in the treatment of hematological malignancies, and cell therapy may become the main force in the treatment of refractory and relapsed malignant tumors in the future. The efficacy of CAR T cells as a potential cell therapy in the tre...
Autores principales: | Liu, Qianzhen, Liu, Zengping, Wan, Rongxue, Huang, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496667/ https://www.ncbi.nlm.nih.gov/pubmed/36139611 http://dx.doi.org/10.3390/cancers14184452 |
Ejemplares similares
-
PKIB involved in the metastasis and survival of osteosarcoma
por: Wan, Rongxue, et al.
Publicado: (2022) -
CAR-T cell therapy for hematological malignancies: Limitations and optimization strategies
por: Huang, Jiawen, et al.
Publicado: (2022) -
Challenges and optimal strategies of CAR T therapy for hematological malignancies
por: Zhang, Yajing, et al.
Publicado: (2023) -
CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working
por: Zhu, Yuxuan, et al.
Publicado: (2023) -
CAR T-Cell Therapy in Hematological Malignancies
por: Haslauer, Theresa, et al.
Publicado: (2021)